Eczema is not classified as an autoimmune disease, though it shares some features with autoimmune conditions
Eczema—most commonly atopic dermatitis—involves inflammation of the skin, but it does not work the way autoimmune diseases do. In autoimmune conditions like rheumatoid arthritis or lupus, the immune system actively attacks the body's own tissues. In eczema, the problem is different: the skin barrier is defective, and the immune system overreacts to irritants and allergens that would not bother most people. The inflammation you see is a response to that breach, not an attack on skin cells themselves.
That said, eczema and autoimmune diseases do overlap in important ways. People with eczema have higher rates of other autoimmune and allergic conditions—asthma, hay fever, food allergies, and sometimes thyroid disease. The immune dysfunction in eczema is real; it is just organized differently than in diseases where the immune system has learned to target "self" tissue. Understanding this distinction matters because it shapes how doctors think about treatment and what you might expect over time.
Key Takeaways
- Eczema is classified as an inflammatory and allergic condition, not an autoimmune disease, because the immune system is not attacking the skin itself.
- The core problem in eczema is a defective skin barrier combined with an overactive immune response to irritants and allergens.
- People with eczema have higher rates of other allergic and autoimmune conditions, suggesting shared underlying immune dysfunction.
- Treatments for eczema differ from those for autoimmune diseases because the mechanism is different, though some medications overlap.
How the immune system works differently in eczema versus autoimmune disease
An autoimmune disease occurs when the immune system produces antibodies or immune cells that attack the body's own tissues. In rheumatoid arthritis, the immune system attacks joint linings. In type 1 diabetes, it attacks insulin-producing cells in the pancreas. Doctors can usually detect these attacks with blood tests that show specific antibodies or immune markers.
Eczema does not follow this pattern. Most people with eczema do not have antibodies against their own skin. Instead, their immune system is primed to overreact to common irritants—soaps, fragrances, dust mites, certain fabrics—and allergens like pollen or pet dander. The inflammation happens because the immune response is too strong for the trigger, not because the immune system has mistaken skin for an invader. This is why eczema is grouped with allergic and inflammatory conditions rather than autoimmune ones.
The skin barrier itself is also abnormal in eczema. People with eczema often have mutations in the gene that codes for filaggrin, a protein that helps hold the outer layer of skin together. Without enough filaggrin, the barrier leaks. Water escapes, irritants and allergens get in, and the immune system responds to the breach. This is a structural problem as much as an immune one.
Why eczema and autoimmune diseases often occur together
People with eczema have higher rates of autoimmune and allergic diseases than the general population. Someone with atopic dermatitis is more likely to develop asthma, hay fever, food allergies, celiac disease, and thyroid autoimmune conditions. This clustering is sometimes called the "atopic march" or "atopic syndrome," and it suggests that eczema and these other conditions share some underlying immune vulnerability.
The connection is not fully understood, but researchers believe it involves how the immune system is trained early in life. Exposure to allergens through a damaged skin barrier may prime the immune system to overreact to those same allergens when encountered through other routes—the lungs (asthma), the nose (hay fever), the gut (food allergies). Some of the same genes that increase eczema risk also increase risk for autoimmune disease, though having the gene does not may provide you will develop either condition.
This overlap can make diagnosis confusing. If you have eczema and develop joint pain or fatigue, your doctor may test for autoimmune disease. It is possible to have both eczema and an autoimmune condition, but one does not cause the other.
What blood tests show about eczema and autoimmunity
Blood tests for autoimmune disease look for specific markers: antibodies against tissue components (like anti-nuclear antibodies in lupus), or elevated levels of inflammatory proteins like rheumatoid factor. Most people with eczema do not have these markers. Their blood work is often normal, or shows only nonspecific signs of inflammation like elevated IgE (an antibody involved in allergic responses).
Elevated IgE is common in eczema, especially in people with the atopic form, but it is not a sign of autoimmune disease. IgE is the antibody your immune system makes in response to allergens. High levels mean your immune system is primed to react to environmental triggers, not that it is attacking your own tissues.
If your doctor suspects you have both eczema and an autoimmune condition, they will order specific tests based on your symptoms—thyroid antibodies if you have fatigue and weight changes, tissue antibodies if you have joint pain or rashes beyond eczema. The absence of these markers in someone with eczema is reassuring; it means the skin inflammation is not part of a systemic autoimmune process.
How treatment differs between eczema and autoimmune diseases
Because eczema is not autoimmune, the standard treatments do not target the immune system the way autoimmune treatments do. The first line of eczema treatment is skin care: moisturizers to repair the barrier, and avoiding irritants and known allergens. Topical corticosteroids or calcineurin inhibitors reduce inflammation during flares. These are anti-inflammatory, not immunosuppressive.
For moderate to severe eczema, doctors may prescribe dupilumab (Dupixent), a monoclonal antibody that blocks specific immune signals involved in allergic inflammation. Dupilumab is not an autoimmune treatment in the traditional sense—it does not suppress the entire immune system—but it does target immune pathways. Other newer treatments like tralokinumab (Adtralza) work similarly.
Autoimmune disease treatments, by contrast, often aim to suppress or redirect the immune system more broadly. Medications like methotrexate or biologics that block TNF-alpha are used for rheumatoid arthritis and other autoimmune conditions. These are rarely used for eczema alone, though someone with both eczema and an autoimmune disease might receive them for the autoimmune condition, with the eczema managed separately.
When eczema symptoms might suggest something autoimmune
Most eczema stays localized to the skin and follows a predictable pattern: flares triggered by irritants, allergens, stress, or weather, followed by periods of improvement. But sometimes skin symptoms suggest something more systemic. Red flags that warrant testing for autoimmune disease include: a rash that does not respond to standard eczema treatment, rash in unusual locations (palms, soles, inside the mouth), joint pain or swelling, dry eyes or dry mouth, fatigue out of proportion to skin symptoms, or a family history of autoimmune disease.
If you have eczema and develop any of these features, tell your doctor. They may order autoimmune screening tests. Finding out whether you have an additional autoimmune condition changes management—not because eczema is autoimmune, but because you would need treatment for both.
It is also worth noting that some skin conditions that look like eczema are actually autoimmune. Discoid lupus, for example, causes round, scarring rashes that can resemble severe eczema. A dermatologist can usually distinguish these with a skin biopsy if the diagnosis is unclear.
The role of genetics and environment in eczema inflammation
Eczema develops when genetic predisposition meets environmental triggers. The genetic side includes mutations in filaggrin and other genes that control skin barrier function and immune response. The environmental side includes irritants (soaps, detergents, chlorine), allergens (dust mites, pet dander, pollen), stress, and infections.
This gene-plus-environment model is different from autoimmune disease, where the genetic risk is often about immune tolerance—the system's ability to recognize "self" and not attack it. In eczema, the genetic risk is about barrier function and allergic sensitivity. This is why eczema can improve dramatically with environmental control (moisturizing, avoiding triggers) in ways that autoimmune diseases typically cannot.
Understanding this can help you manage eczema more effectively. If you have a family history of eczema, you are at higher genetic risk, but you can still reduce flares by protecting your skin barrier and avoiding known triggers. This is not possible with autoimmune disease, where the immune system dysfunction is internal and cannot be managed by external avoidance alone.
Frequently Asked Questions
Can eczema turn into an autoimmune disease?
No. Eczema is a chronic condition that may improve or worsen over time, but it does not transform into an autoimmune disease. However, people with eczema have higher rates of developing other autoimmune conditions like thyroid disease or celiac disease. These are separate conditions that happen to occur more often in people with eczema, not a progression from eczema itself.
If I have eczema and test positive for autoimmune antibodies, what does that mean?
It means you may have both eczema and an autoimmune condition. The antibodies indicate an autoimmune process, which is separate from the eczema. Your doctor will evaluate your symptoms and may order additional tests to confirm which autoimmune condition you have and how to treat it alongside your eczema.
Why do people with eczema get asthma and allergies so often?
The exact reason is not fully known, but researchers believe a damaged skin barrier in eczema allows allergens to enter the body more easily, priming the immune system to overreact to those allergens. This same overreactive immune response can then occur in the lungs (asthma) or nose (hay fever) when you encounter the allergen again. Shared genetic factors also play a role.
Does having eczema mean I will develop an autoimmune disease?
No. While people with eczema have higher rates of autoimmune disease than the general population, most people with eczema never develop an autoimmune condition. Having eczema increases your risk, but it does not make autoimmune disease inevitable. Regular check-ups with your doctor can catch early signs of other conditions if they do develop.
Are the medications for eczema the same as for autoimmune diseases?
Not usually. Eczema is treated with moisturizers, topical anti-inflammatory medications, and sometimes targeted biologics like dupilumab. Autoimmune diseases are often treated with broader immunosuppressive medications like methotrexate or TNF-blocking biologics. Some newer eczema treatments do target specific immune pathways, but they work differently than traditional autoimmune treatments.